Mulliken JB, Glowacki J. Hemangiomas and vascular
malformations in infants and children: a classification based
on endothelial characteristics....
Ricci KW. Advances in the medical management of vascular
anomalies. Semin Intervent Radiol. 2017;34(3):239–249. https://
doi.org/10.1055/s-0037-1604297.
Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, et al. A
randomized, controlled trial of oral propranolol in infantile
hemangioma. N Engl...
Jinnin M, Medici D, Park L, et al. Suppressed NFAT-dependent
VEGFR1 expression and constitutive VEGFR2 signaling in
infantile hemangioma....
Berenguer B, Mulliken JB, Enjolras O, et al. Rapidly involuting
congenital hemangioma: clinical and histopathologic features. Pediatr Dev...
Ayturk UM, Couto JA, Hann S, et al. Somatic activating
mutations in GNAQ and GNA11 are associated with congenital
hemangioma. Am J Hum Genet....
Wang Z, Yao W, Sun H, et al. Sirolimus therapy for kaposiform
hemangioendothelioma with long-term follow-up. J Dermatol.
2019;46(11):956–961....
Nguyen HL, Boon LM, Vikkula M. Vascular anomalies caused
by abnormal signaling within endothelial cells: targets for
novel therapies. Semin...
Kim JS, Hwang SK, Chung HY. The molecular pathophysiology
of vascular anomalies: genomic research. Arch Plast Surg. 2020;
47(3):203–208. https://doi.org/10.5999/aps.2020.00591.
Couto JA, Vivero MP, Kozakewich HPW, et al. A somatic
MAP3K3 mutation Is associated with verrucous venous
malformation. Am J Hum Genet. 2015;96(3):480–486....
Boscolo E, Limaye N, Huang L, et al. Rapamycin improves
TIE2-mutated venous malformation in murine model and
human subjects. J Clin Invest....
Isoldi S, Belsha D, Yeop I, et al. Diagnosis and management of
children with blue rubber bleb nevus syndrome: a multicenter case series. Dig...
Lekwuttikarn R, Lim YH, Admani S, Choate KA, Teng JMC.
Genotype-guided medical treatment of an arteriovenous
malformation in a child. JAMA...
Triana Junco PE, Sánchez-Carpintero I, López-Gutiérrez JC.
Preventive treatment with oral sirolimus and aspirin in a
newborn with severe Sturge-Weber...
Eerola I, Boon LM, Mulliken JB, et al. Capillary malformationarteriovenous malformation, a new clinical and genetic
disorder caused by RASA1...
Amyere M, Revencu N, Helaers R, et al. Germline loss-offunction mutations in EPHB4 cause a second form of capillary
malformation-arteriovenous...
Hammill AM, Wentzel M, Gupta A, et al. Sirolimus for the
treatment of complicated vascular anomalies in children.
Pediatr Blood Cancer. 2011;57(6):1018–1024....
Ivars M, Redondo P. Efficacy of topical sirolimus (Rapamycin)
for the treatment of microcystic lymphatic malformations.
JAMA Dermatol. 2017;153(1):103–105....
Triana P, Miguel M, Díaz M, López-Gutierrez JC. Clinical
monitoring challenges in the pharmacological treatment and
management of lymphatic...
Li D, March ME, Gutierrez-Uzquiza A, et al. ARAF recurrent
mutation causes central conducting lymphatic anomaly
treatable with a MEK inhibitor....
Venot Q, Blanc T, Rabia SH, et al. Targeted therapy in patients
with PIK3CA-related overgrowth syndrome. Nature. 2018;558
(7711):540–546....
